GB0203665D0 - Process - Google Patents

Process

Info

Publication number
GB0203665D0
GB0203665D0 GBGB0203665.5A GB0203665A GB0203665D0 GB 0203665 D0 GB0203665 D0 GB 0203665D0 GB 0203665 A GB0203665 A GB 0203665A GB 0203665 D0 GB0203665 D0 GB 0203665D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0203665.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0203665.5A priority Critical patent/GB0203665D0/en
Publication of GB0203665D0 publication Critical patent/GB0203665D0/en
Priority to JP2003567860A priority patent/JP2005517703A/en
Priority to PCT/EP2003/001607 priority patent/WO2003068725A2/en
Priority to EP03739500A priority patent/EP1474405A2/en
Priority to AU2003210296A priority patent/AU2003210296A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
GBGB0203665.5A 2002-02-15 2002-02-15 Process Ceased GB0203665D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0203665.5A GB0203665D0 (en) 2002-02-15 2002-02-15 Process
JP2003567860A JP2005517703A (en) 2002-02-15 2003-02-14 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
PCT/EP2003/001607 WO2003068725A2 (en) 2002-02-15 2003-02-14 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
EP03739500A EP1474405A2 (en) 2002-02-15 2003-02-14 Process for the preparation of 4-hetero-substituted phenylalanine derivatives
AU2003210296A AU2003210296A1 (en) 2002-02-15 2003-02-14 Process for the preparation of 4-hetero-substituted phenylalanine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0203665.5A GB0203665D0 (en) 2002-02-15 2002-02-15 Process

Publications (1)

Publication Number Publication Date
GB0203665D0 true GB0203665D0 (en) 2002-04-03

Family

ID=9931182

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0203665.5A Ceased GB0203665D0 (en) 2002-02-15 2002-02-15 Process

Country Status (5)

Country Link
EP (1) EP1474405A2 (en)
JP (1) JP2005517703A (en)
AU (1) AU2003210296A1 (en)
GB (1) GB0203665D0 (en)
WO (1) WO2003068725A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213122D0 (en) * 2002-06-07 2002-07-17 Glaxo Group Ltd Compounds
JP2020193181A (en) * 2019-05-30 2020-12-03 東ソー株式会社 Method for producing aromatic nitrile compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277737B1 (en) * 1995-12-28 1997-11-12 Zambon Spa TIOLIC DERIVATIVES FOR METALLOPEPTIDASE INHIBITIVE ACTIVITY

Also Published As

Publication number Publication date
AU2003210296A8 (en) 2003-09-04
AU2003210296A1 (en) 2003-09-04
JP2005517703A (en) 2005-06-16
WO2003068725A2 (en) 2003-08-21
EP1474405A2 (en) 2004-11-10
WO2003068725A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
GB0213599D0 (en) Process
GB0210143D0 (en) Process
GB0211789D0 (en) Process
GB0225701D0 (en) Process
GB0213485D0 (en) Process
GB0205016D0 (en) Process
GB0204607D0 (en) Process
GB0201505D0 (en) Process
GB0202564D0 (en) Process
GB0205014D0 (en) Process
GB0201378D0 (en) Process
GB0202563D0 (en) Process
GB0212974D0 (en) Process
GB0210183D0 (en) Process
GB0218014D0 (en) Process
GB0219292D0 (en) Process
GB0203665D0 (en) Process
GB0219829D0 (en) Process
GB0222619D0 (en) Process
GB0210185D0 (en) Process
GB0228894D0 (en) Process
GB0212651D0 (en) Process
GB0200220D0 (en) Process
GB0205448D0 (en) Process
GB0212463D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)